155 related articles for article (PubMed ID: 37980163)
1. Prognostic hub gene CBX2 drives a cancer stem cell-like phenotype in HCC revealed by multi-omics and multi-cohorts.
Meng Q; Zhou Q; Chen X; Chen J
Aging (Albany NY); 2023 Nov; 15(22):12817-12851. PubMed ID: 37980163
[TBL] [Abstract][Full Text] [Related]
2. CBX2-mediated suppression of SIAH2 triggers WNK1 accumulations to promote glycolysis in hepatocellular carcinoma.
Xu Z; Wu Y; Yang M; Wei H; Pu J
Exp Cell Res; 2023 May; 426(1):113513. PubMed ID: 36780970
[TBL] [Abstract][Full Text] [Related]
3. SPAG5 interacts with CEP55 and exerts oncogenic activities via PI3K/AKT pathway in hepatocellular carcinoma.
Yang YF; Zhang MF; Tian QH; Fu J; Yang X; Zhang CZ; Yang H
Mol Cancer; 2018 Aug; 17(1):117. PubMed ID: 30089483
[TBL] [Abstract][Full Text] [Related]
4. Identification of hepatocellular carcinoma subtypes based on PcG-related genes and biological relevance with cancer cells.
Fu Y; Yang K; Wu K; Wang H; Li Q; Zhang F; Yang K; Yao Q; Ma X; Deng Y; Zhang J; Liu C; Qu K
Clin Epigenetics; 2022 Dec; 14(1):184. PubMed ID: 36566204
[TBL] [Abstract][Full Text] [Related]
5. Upregulation of CEP55 Predicts Dismal Prognosis in Patients with Liver Cancer.
Yang L; He Y; Zhang Z; Wang W
Biomed Res Int; 2020; 2020():4139320. PubMed ID: 32337246
[TBL] [Abstract][Full Text] [Related]
6. α-catenin interaction with YAP/FoxM1/TEAD-induced CEP55 supports liver cancer cell migration.
Tang Y; Thiess L; Weiler SME; Tóth M; Rose F; Merker S; Ruppert T; Schirmacher P; Breuhahn K
Cell Commun Signal; 2023 Jun; 21(1):162. PubMed ID: 37381005
[TBL] [Abstract][Full Text] [Related]
7. CBX2 is a functional target of miRNA let-7a and acts as a tumor promoter in osteosarcoma.
Han Q; Li C; Cao Y; Bao J; Li K; Song R; Chen X; Li J; Wu X
Cancer Med; 2019 Jul; 8(8):3981-3991. PubMed ID: 31150156
[TBL] [Abstract][Full Text] [Related]
8. SP1-induced upregulation of lncRNA CTBP1-AS2 accelerates the hepatocellular carcinoma tumorigenesis through targeting CEP55 via sponging miR-195-5p.
Liu LX; Liu B; Yu J; Zhang DY; Shi JH; Liang P
Biochem Biophys Res Commun; 2020 Dec; 533(4):779-785. PubMed ID: 32988587
[TBL] [Abstract][Full Text] [Related]
9. Nuclear condensates of the Polycomb protein chromobox 2 (CBX2) assemble through phase separation.
Tatavosian R; Kent S; Brown K; Yao T; Duc HN; Huynh TN; Zhen CY; Ma B; Wang H; Ren X
J Biol Chem; 2019 Feb; 294(5):1451-1463. PubMed ID: 30514760
[TBL] [Abstract][Full Text] [Related]
10. Osteopontin promotes a cancer stem cell-like phenotype in hepatocellular carcinoma cells via an integrin-NF-κB-HIF-1α pathway.
Cao L; Fan X; Jing W; Liang Y; Chen R; Liu Y; Zhu M; Jia R; Wang H; Zhang X; Zhang Y; Zhou X; Zhao J; Guo Y
Oncotarget; 2015 Mar; 6(9):6627-40. PubMed ID: 25749383
[TBL] [Abstract][Full Text] [Related]
11. Bioinformatics analysis of the interactions among lncRNA, miRNA and mRNA expression, genetic mutations and epigenetic modifications in hepatocellular carcinoma.
Lin C; Yuan G; Hu Z; Zeng Y; Qiu X; Yu H; He S
Mol Med Rep; 2019 Feb; 19(2):1356-1364. PubMed ID: 30535497
[TBL] [Abstract][Full Text] [Related]
12. Beyond EZH2: is the polycomb protein CBX2 an emerging target for anti-cancer therapy?
Jangal M; Lebeau B; Witcher M
Expert Opin Ther Targets; 2019 Jul; 23(7):565-578. PubMed ID: 31177918
[No Abstract] [Full Text] [Related]
13. [Studies on the role of chromobox protein homolog 2 in the inhibition of progression of hepatoma].
Li J; Guo ZX; Chen JA; Xue C; Sun LL; Ren ZG; Li A; Cui GY; Yu ZJ
Zhonghua Gan Zang Bing Za Zhi; 2019 Mar; 27(3):192-197. PubMed ID: 30929335
[No Abstract] [Full Text] [Related]
14. CBX2 shapes chromatin accessibility promoting AML via p38 MAPK signaling pathway.
Del Gaudio N; Di Costanzo A; Liu NQ; Conte L; Dell'Aversana C; Bove G; Benedetti R; Montella L; Ciardiello F; Carafa V; Ambrosino C; Tucci V; Conte M; Martens JHA; Stunnenberg HG; Nebbioso A; Altucci L
Mol Cancer; 2022 Jun; 21(1):125. PubMed ID: 35681235
[TBL] [Abstract][Full Text] [Related]
15. CBX2 Regulates Proliferation and Apoptosis via the Phosphorylation of YAP in Hepatocellular Carcinoma.
Mao J; Tian Y; Wang C; Jiang K; Li R; Yao Y; Zhang R; Sun D; Liang R; Gao Z; Wang Q; Wang L
J Cancer; 2019; 10(12):2706-2719. PubMed ID: 31258779
[TBL] [Abstract][Full Text] [Related]
16. CBX2 Induces Glioma Cell Proliferation and Invasion Through the Akt/PI3K Pathway.
Wang L; Ren B; Zhuang H; Zhong Y; Nan Y
Technol Cancer Res Treat; 2021; 20():15330338211045831. PubMed ID: 34709960
[TBL] [Abstract][Full Text] [Related]
17. M2-like tumor-associated macrophage-related biomarkers to construct a novel prognostic signature, reveal the immune landscape, and screen drugs in hepatocellular carcinoma.
Qu X; Zhao X; Lin K; Wang N; Li X; Li S; Zhang L; Shi Y
Front Immunol; 2022; 13():994019. PubMed ID: 36177006
[TBL] [Abstract][Full Text] [Related]
18. Identification and validation of a prognostic four-genes signature for hepatocellular carcinoma: integrated ceRNA network analysis.
Yan Y; Lu Y; Mao K; Zhang M; Liu H; Zhou Q; Lin J; Zhang J; Wang J; Xiao Z
Hepatol Int; 2019 Sep; 13(5):618-630. PubMed ID: 31321712
[TBL] [Abstract][Full Text] [Related]
19. Prognostic value of long non-coding RNA
Liao X; Chen J; Luo D; Luo B; Huang W; Xie W
Pathol Oncol Res; 2022; 28():1610808. PubMed ID: 36685103
[No Abstract] [Full Text] [Related]
20. Upregulation of centrosomal protein 55 is associated with unfavorable prognosis and tumor invasion in epithelial ovarian carcinoma.
Zhang W; Niu C; He W; Hou T; Sun X; Xu L; Zhang Y
Tumour Biol; 2016 May; 37(5):6239-54. PubMed ID: 26615423
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]